Diabetic Foot Ulcers Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis:  By Treatment Type (Wound Care Dressings, Wound Care Devices, Biologics), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings) and Region

Diabetic Foot Ulcers Treatment Market size was valued at US$ 7.6 billion in 2023 and is poised to grow at a significant CAGR of 9.8% from 2024-2030. Diabetic foot ulcers are the full-thickness wounds present below the ankle in diabetic patients. The risk factors for the diabetic foot ulcers include poor blood circulation, neuropathy, and insufficiently well controlled diabetes are among others. Pressure ulcers or bedsores are injuries to skin and underlying tissue, caused by the prolonged pressure on skin. Pressure ulcers are majorly affect the persons with paralysis, old age, illness, and frailty. The diabetic foot ulcer (DFU) treatment market refers to the industry focused on the development, production, and distribution of treatments for diabetic foot ulcers. These ulcers are a common complication of diabetes, often resulting from poor blood circulation and nerve damage in the feet.

The aging population is another element driving the market for diabetic foot ulcer treatments. People who are older are more likely to develop diabetes, peripheral neuropathy, peripheral artery disease, and other chronic conditions that increase the chance of developing foot ulcers. The growing population of elderly people is driving the demand for novel therapies for diabetic foot ulcers. A variety of factors, such as an increase in the elderly population, a rise in the number of persons with diabetes, and advancements in wound care management technologies, are driving the growth of the diabetic foot ulcer treatment market. The rising global prevalence of diabetes is one of the main factors driving the market.